+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Type I Hypersensitivity"

Allergy Immunoassay Brief - Product Thumbnail Image

Allergy Immunoassay Brief

  • Report
  • September 2021
  • 53 Pages
  • Global
From
Immunology. Edition No. 9 - Product Thumbnail Image

Immunology. Edition No. 9

  • Book
  • March 2020
  • 3 Results (Page 1 of 1)
Loading Indicator

Type I Hypersensitivity is a form of allergic reaction caused by the body's immune system overreacting to a foreign substance, such as pollen, pet dander, or dust mites. This reaction is mediated by immunoglobulin E (IgE) antibodies, which trigger the release of histamine and other inflammatory mediators. Symptoms of Type I Hypersensitivity can range from mild to severe, and can include sneezing, itching, hives, and anaphylaxis. The Allergy and Immunology market is a rapidly growing field, with a focus on the diagnosis and treatment of allergic and immunologic diseases. This includes the diagnosis and treatment of Type I Hypersensitivity, as well as other allergic and immunologic conditions. Treatment options for Type I Hypersensitivity include allergen avoidance, immunotherapy, and medications such as antihistamines and corticosteroids. Companies in the Type I Hypersensitivity market include Allergan, Merck, Sanofi, and Teva Pharmaceuticals. Show Less Read more